The Endocrine Society recently held a virtual Science Writers Conference dedicated to the current landscape and future horizons of GLP-1 therapies, examining new oral formulations and dual and triple agonists. Endocrine News caught up with the two experts who spoke at the conference — Priya Jaisinghani, MD, DABOM and Mehmet Furkan Burak, MD – to...
Author: Derek Bagley
As the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) expands, so too does our knowledge of just what all these medications can do. GLP-1RAs have now been shown to reduce consumption of alcohol and drugs, even treating addictions to gambling and sex, but these medications can also potentially lead to rare but fatal complications of... As the onslaught of anti-obesity drugs hit the market in recent years, more research is being released about their potential side effects as well as their benefits. Endocrine News investigates two of these studies to gain more insight to how these “miracle drugs” could affect cardiac health. Two studies published in late 2025 examined cardiovascular...New Study May Offer Hope to Women Suffering Menopausal Hot Flashes, Night Sweats
A woman’s insulin levels in midlife are linked to the timing and duration of menopausal hot flashes, night sweats and cold sweats, according to new research from the University of Victoria (UVic). The study found that having higher insulin levels at age 47 predicted younger onsets of hot flashes and night sweats,” says Faria Athar, lead author...
A new study led by Mayo Clinic found that postmenopausal women receiving menopausal hormone therapy lost 35% more weight while taking tirzepatide. The findings, published in The Lancet Obstetrics, Gynaecology, & Women’s Health, could expand treatment possibilities for millions of women struggling with obesity and obesity-related diseases after menopause. Menopause can accelerate age-related weight gain and increase the likelihood of...
New Directions in Thyroid Care: Minimizing Risk, Maximizing Choice
From how radioiodine therapy for Graves’ disease impacts cancer occurrence and the potential usefulness of pharmacologic treatment for benign thyroid nodules to how a minimally invasive procedure could be the preferred treatment option, recent studies from The Journal of Clinical Endocrinology & Metabolism further demonstrate how endocrine science is benefiting patients around the world. As...
For the eleventh year running, Endocrine News talks to editors from Endocrine Society publications to unearth the most impressive breakthroughs in endocrine science and research for 2025. From GLP-1s, adrenal treatments, and acromegaly breakthroughs to obesity, diabetes, and cutting-edge research in reproductive medicine, 2025 was a banner year for endocrine research and researchers! For more...Quality Time: How Endocrine Society Journals Continue to Maintain the Highest Standards Possible
Scientific journal integrity is increasingly being threatened with the rise of predatory journals, fraudulent papers, and even nonsensical submissions. On January 28 this year the Endocrine Society released a statement warning members against solicitations from a journal called “Journal of Endocrinology and Metabolism.” The Society cannot verify the authenticity or accuracy of this “journal” with...
